Inventor

SHEN DONG-MING

US63 patents

⚠️ This page may combine multiple inventors who share the name “SHEN DONG-MING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHEN DONG-MING

MOBIL OIL CORP

Nitrogenous 1,3-substituted adamantanes

High viscosity index lubricant fluid

Diamondoid-containing amines

Diamondoid derivatives for pharmaceutical use

Synthesis of 4-hydroxy-2-adamantanes and related compounds

Synthesis of adamantane-2,4-dione

Oxidative coupling of diamondoids and aromatics

Synthesis of adamantane-2,4-dione

Air hydroxylation of diamondoids

Deposit control additives and fuel compositions containing the same

Fiber optic cable and viscous filler material

Fiber optic cable and viscous filler material

Lubricant composition and method for increasing diamondoid incorporation in polyalphaolefin-containing lubricant

Method for making diamondoid lubricant base stock by alkylation with an olefin in the presence of a Lewis acid

MERCK & CO INC

Pyrrolidine modulators of chemokine receptor activity

Cyclopentyl modulators of chemokine receptor activity

Substituted pyrazoles, compositions containing such compounds and methods of use

Pyrrolidine modulators of CCR5 chemokine receptor activity

N-cyclopentyl modulators of chemokine receptor activity

Ophthalmic compositions for treating ocular hypertension

Ophthalmic compositions for treating ocular hypertension

Ophthalmic compositions for treating ocular hypertension

N-cyclopentyl modulators of chemokine receptor activity

Pyrrolidine modulators of CCR5 chemokine receptor activity

MERCK SHARP & DOHME

Pyrrolidine derived beta 3 adrenergic receptor agonists

Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors

Substituted pyrazoles, compositions containing such compounds and methods of use

Mineralocorticoid receptor antagonists

Mineralocorticoid receptor antagonists

Piperazine derivatives as HIV protease inhibitors

Factor XIA inhibitors

NOVARTIS AG

Compounds and compositions for treating conditions associated with NLRP activity

Compounds and compositions for treating conditions associated with NLRP activity

Compounds and compositions for treating conditions associated with NLRP activity

Compounds and compositions for treating conditions associated with NLRP activity

Compounds and compositions for treating conditions associated with NLRP activity

Compounds and compositions for treating conditions associated with NLRP activity

Compounds and compositions for treating conditions associated with NLRP activity

Sulphonamides and compositions thereof for treating conditions associated with NLRP activity

BERGER RICHARD

Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists

Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

CRESPO ALEJANDRO

Mineralocorticoid receptor antagonists

DING FA-XIANG

Spiropiperidine prolylcarboxypeptidase inhibitors

NOVARTIS INFLAMMASOME RES INC

Compounds and compositions for treating conditions associated with NLRP activity

SHEN DONG-MING

Direct backlight module supporting apparatus and direct backlight module

ALI AMJAD

Cicletanine derivatives

HALE JEFFREY J

Prolylcarboxypeptidase inhibitors